Publication | Open Access
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
32
Citations
17
References
2020
Year
ACE2 levels are upregulated in some patient groups with comorbidities linked to COVID-19 and as such may have an emerging role as a circulating biomarker for severity of outcome in COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1